randomized-controlled-trial

To design a randomized controlled trial protocol, define the PICO criteria, select a trial design type, calculate the appropriate sample size, and establish randomization and blinding schemes. This ensures methodological transparency and regulatory compliance from execution to reporting.

Calculating sample size and setting up randomization for clinical trials requires predefining your trial design type and planned outcomes. Using a structured protocol ensures your randomization schemes and sample size calculations align with the predefined statistical analysis plan.

Blinding in a randomized controlled trial design conceals intervention allocation from participants, investigators, or outcome assessors. A structured protocol helps pre-specify blinding strategies alongside randomization schemes to minimize bias during execution and reporting.

Yes, you can use this protocol for non-inferiority and equivalence trial designs, as well as superiority trials. It guides PICO construction, sample size calculations, and outcome definitions tailored to your specific trial design type and analysis plan.

Yes, following CONSORT reporting guidelines is essential for documenting a clinical trial. The protocol provides a CONSORT-aligned reporting blueprint covering registration, ethical approvals, data collection, and predefined outcomes to ensure regulatory compliance.

A predefined RCT protocol is limited to medical and health intervention trials and relies on strict adherence to pre-specified outcomes, sample sizes, and statistical analysis plans. Deviating from predefined criteria during execution compromises methodological transparency and regulatory compliance.